The functional importance of gene enhancers in regulated gene expression is well established [1] [2] [3] . In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells [4] [5] [6] , bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs) [7] [8] [9] . However, it has remained unclear whether these eRNAs are functional or merely a reflection of enhancer activation. Here we report that in human breast cancer cells 17b-oestradiol (E2)-bound oestrogen receptor a (ER-a) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes. These induced eRNAs, as functional transcripts, seem to exert important roles for the observed ligand-dependent induction of target coding genes, increasing the strength of specific enhancer-promoter looping initiated by ER-a binding. Cohesin, present on many ER-aregulated enhancers even before ligand treatment, apparently contributes to E2-dependent gene activation, at least in part by stabilizing E2/ER-a/eRNA-induced enhancer-promoter looping. Our data indicate that eRNAs are likely to have important functions in many regulated programs of gene transcription.
We performed ER-a chromatin immunoprecipitation coupled with massively parallel DNA sequencing (ChIP-Seq) analysis using 1 h E2-treated (100 nM) MCF-7 human breast cancer cells and revealed 31,052 ER-a binding sites genome wide. This included only 902 on promoters ( Supplementary Fig. 1a ), in accordance with previously reported analyses [10] [11] [12] , and 7,174 ER-a-bound potential enhancers based on the presence of H3K4me1 (refs 13, 14) and H3K27ac (ref. 15) (Supplementary Fig. 1b ). Global run-on sequencing (GRO-seq) analysis of MCF-7 cells in similar conditions identified 1,309 E2-upregulated coding genes, of which 1,145 had an E2/ER-a-binding enhancer within 200 kilobases (kb) from their transcription start site (TSS) and were thus considered to be direct oestrogen-upregulated target genes (hereafter referred to as UP genes; Supplementary Fig. 1c ). Of these, only 112 showed ER-a binding to their promoters ( Supplementary Fig. 1c ), consistent with suggestions 10, 11 that ER-a occupancy on enhancers is a key strategy underlying E2-induced gene expression. Most E2-regulated enhancers showed a rapid bidirectional activation of eRNAs, exemplified by the FOXC1 locus ( Supplementary Fig. 1e) , which is about ,1.5 kb long as identified by GRO-seq, although ,10% exhibited an apparent unidirectional eRNA transcription 8 ( Fig. 1a and Supplementary Fig. 1f, g ). These data suggest that eRNA induction in response to ER-a binding is a predictive mark of enhancer activity 9 . Binding of ER-a did not cause clear alterations in enhancer marks on ER-a-bound enhancers, such as H3K27ac ( Supplementary Fig. 1h ).
Approximately 83% of enhancers with detectable GRO-seq signals adjacent to UP genes exhibited E2-induced eRNA upregulation (Fig. 1a) ; for the remaining 17%, the tag count was not sufficient to assign upregulation bioinformatically. E2 induction of eRNA was not observed on non-ER-a-bound H3K27ac-marked enhancers ( Supplementary Fig. 1i ). The median distance between enhancers exhibiting E2-induced eRNAs (n 5 1,248; referred to as UP enhancers) and their closest UP genes was ,52 kb, compared with a median distance of ,270 kb between enhancers exhibiting no E2 induction of of GRO-seq showing bidirectional eRNA transcription at enhancers induced by E2. b, UP enhancers are closer to the UP genes (median ,52 kb) in comparison to enhancers with non-upregulated eRNAs (median ,270 kb). Up arrows indicate upregulation. c, ER-a binds more robustly to UP enhancers than to the enhancers with non-upregulated eRNA. d, Among the UP enhancers, the proximal ones within 200 kb from any E2-upregulated gene TSSs exhibit higher ER-a binding intensity than the distal cohort of UP enhancers located farther away. e, Most of the UP enhancers are in close proximity to E2-upregulated coding genes. f, ER-a binding intensity on UP enhancers is higher than on 112 promoters of E2-activated genes, which itself is higher than the 790 ER-a-bound promoters of genes did not show upregulation by E2. A log 10 scale is used for panels b, c and f. P values are given at the top of graphs, and were calculated using the Student's t-test. eRNAs with UP genes (Fig. 1b) . ChIP-Seq analysis revealed that UP enhancers showed significantly stronger binding of ER-a than enhancers not exhibiting eRNA upregulation (Fig. 1c) . Proximal (,200 kb) UP enhancers constituted a majority of all UP enhancers and had a higher affinity for ER-a than did distal UP enhancers (Fig. 1d, e) . The strength of ER-a binding was much higher on UP enhancers than on 112 ER-a-bound promoters of coding genes that showed E2 induction, whereas the remaining 790 ER-a-bound promoters of genes with no E2 upregulation exhibited the weakest ER-a binding (Fig. 1f) .
On the basis of GRO-seq analyses, we selected ten highly upregulated transcription units for further experimentation, each associated with adjacent UP enhancers exhibiting ,2.5-5-fold E2 induction of eRNAs (Supplementary Fig. 1j ). Despite increasing evidence for crucial nuclear functions of lncRNAs [4] [5] [6] , it remains an unresolved question whether eRNAs are merely a by-product of enhancer activation or whether they might serve as key regulators of coding gene transcription [7] [8] [9] . To investigate the potential roles of ligand-induced eRNAs on gene activation events, both specific short interfering RNAs (siRNAs) 16 and locked nucleic acid antisense oligonucleotides (LNAs) 17 directed against each eRNA transcript were designed on the basis of the peaks of eRNA exhibited by GRO-seq. To exclude offtarget effects, experiments were performed with two different LNAs or siRNAs targeting each eRNA.
With a high efficiency of transfection ( Supplementary Fig. 2a ), both siRNA and LNA-mediated knockdown of the TFF1, FOXC1 or CA12 eRNAs revealed that, for each transcription unit, the induction of both the eRNA and of the adjacent coding gene, as assessed by quantitative polymerase chain reaction (qPCR) and GRO-seq, respectively, was significantly inhibited (Fig. 2a, b , e and Supplementary Fig. 2b, c) . By contrast, these siRNAs/LNAs did not affect the housekeeping genes we tested (for example, GAPDH; Fig. 2f ), or E2-regulated or non-E2-regulated transcription units more distal to the regulated enhancers (Fig. 2c, d ). Ligand-induced increase of ER-a binding occurred even after eRNA knockdown ( Supplementary Fig. 2d , e). Similar eRNA requirements for coding-gene induction by E2 were observed on the basis of knockdown of eRNAs adjacent to the PGR, SIAH2, KCNK5, P2RY2, SMAD7, GREB1 and NRIP1 genes using either siRNAs or LNAs (Fig. 3g, i and Supplementary Fig. 2b ). GRO-seq data were consistent with the notion that LNA against eRNA reduces the levels of eRNA transcript post-transcriptionally, but not its nascent transcription (Fig. 2e, bar graph) . Knockdown of an eRNA on an ER-abound distal enhancer (,222 kb from the FOXC1 TSS) that did not exhibit E2-induced eRNA and with low ER-a-binding affinity did not affect neighbouring FOXC1 gene induction ( Supplementary Fig. 2f ), further indicating that eRNA induction potentially marks E2-regulated functional enhancers. Although GRO-seq results (Fig. 2e) already indicate a lack of any LNA-mediated transgene silencing of the enhancer DNA, further assays-including methyl miner and enzyme digestion assays ( Supplementary Fig. 3a-c) -confirmed unaltered enhancer methylation on the FOXC1, P2RY2 or NRIP1 enhancers. Additional supporting evidence was provided by using an LNA targeting the sense transcript from a regulatory region near the GREB1 gene (GREB1-RR), which exhibits overlapping bidirectional transcription (Supplementary Fig. 3d, e) ; we observed no significant change in transcript level from the antisense strand by strand-specific qPCR. We also failed to observe any significant LNA effects on levels of total histone H3, H3K9me3 or H3K27me3 silencing marks on several targeted enhancers ( Supplementary Fig. 3g ). Together, these data suggest that siRNA/ LNA-mediated knockdown of eRNAs does not elicit transgene silencing of the interrogated enhancers.
To validate independently that eRNAs per se are important for quantitative increases in target gene expression, we took advantage 
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of a GAL4-BoxB-tethering-based reporter assay 18 . For this we engineered a chimaeric RNA by fusing FOXC1 sense eRNA to BoxB viral RNA, permitting BoxB-FOXC1 eRNA to be recruited by the RNA binding domain of lN protein fused with the GAL4 DNA binding domain (lN-GAL4). Thus eRNA can be artificially tethered to 53UAS sites just downstream of the FOXC1 enhancer in the reporter plasmid, in which luciferase (Luc) is under the control of the native FOXC1 promoter (Supplementary Fig. 8 ). We observed that the presence of full-length FOXC1 enhancer increased Luc expression to ,2.5 fold when compared to random DNA in place of the enhancer (Fig. 3a, blue bars) . This effect was abolished when the sense eRNA sequence was deleted and substituted with 53UAS sites, generating a non-functional 'missense' eRNA ( Fig. 3a , blue bars, and Supplementary Fig. 8 ). Tethering of BoxB-FOXC1 eRNA, but not BoxB alone, could fully rescue the activity loss of sense-eRNA-deleted enhancer (Fig. 3a, orange bars) , whereas the antisense FOXC1 eRNA could not (Fig. 3b) . We confirmed the loss of plasmid-driven native FOXC1 eRNA expression from the senseeRNA-deleted reporter construct, and showed that GAL4 tethering was not altered (Fig. 3c, d ). These data further support the suggestion that the sequence-specific eRNA transcript per se, rather than merely the process of enhancer transcription, is required for the actions of the eRNA on enhancer-dependent coding-gene activation events. This observation is consistent with recent studies of the role of ncRNAs in p53-dependent gene activation 19 and in regulation of the SNAI1 gene 20 . We next investigated whether enhancer-promoter looping is induced in the E2-activation events 21 , using a strategy analogous to chromosome conformation capture carbon copy (5C), which is named three-dimensional DNA selection and ligation (3D-DSL) 22 , to study the spatial organization of genomes 23, 24 . We first examined two E2-regulated transcription units: P2RY2 and KCNK5. For P2RY2, E2 treatment significantly increased the specific promoter-enhancer interaction (Fig. 3e) , and promoter. 53UAS sites are fused downstream to the FOXC1 enhancer. GAL4-lN fusion protein tethers BoxB-FOXC1 eRNA to the 53UAS sites. Bar graph shows the effects of the FOXC1 eRNA on FOXC1 promoter-driven Luc activity in the presence of E2 (24 h). Blue bars show how the activating function of the native fulllength enhancer (bar 2) over random DNA (bar 1) is lost when the sense eRNA cassette is substituted with the 53UAS site (bar 3). Orange bars show how this loss is largely rescued upon FOXC1 eRNA tethering to the sense-eRNA-deleted enhancer cassette (enh-sense del; bar 6). b, eRNA function is sequence specific: FOXC1e sense eRNA but not antisense strand RNA could rescue the activity of sense-eRNA-deleted enhancer in the tethering assay. c, Gel picture showing plasmid-based eRNA expression from full-length enhancer (enh) but not from the sense-eRNA-deleted enhancer construct (pGL3b-sense-del FOXC1 enh). RT, reverse transcriptase. d, Bar graph showing efficiency of GAL4 tethering on various pGL3b constructs. e, 3D-DSL data for the P2RY2 locus, revealing strengthened promoter-enhancer interactions over basal conditions after 1 h E2 treatment. For all 3D-DSL data, the log 10 intensities of interaction counts plus 1 or 0.25 for presentation purposes are on the y-axis, and the x-axis depicts coordinates from the University of California, Santa Cruz (UCSC) genome browser. Interaction data are overlaid with positions of the enhancer, ER-a-binding sites and HindIII sites on the regions interrogated. The pertinent promoter-enhancer interaction is shown in red and other interactions are shown in blue. E, enhancer; P, promoter. f, 3D-DSL data for the KCNK5 locus after 1 h E2 treatment. g, LNA knockdown of NRIP1 eRNA effectively reduced the levels of both eRNA and associated coding gene transcripts. h, 3D-DSL data demonstrating significant reduction in promoter-enhancer interaction upon treatment of LNA against NRIP1 eRNA. i, GREB1e siRNA knockdown diminished the levels of eRNA and associated coding gene transcript. CTL, control. j, 3D-DSL data for the GREB1 locus showing significantly reduced enhancer-promoter looping as well as other genomic interactions after GREB1e-specific siRNA treatment. Dotted lines in panels e and f represent 2E2 condition, but knockdown situation in panels h and j. Data show mean6 s.d.; (n 5 3). *P , 0.05, **P , 0.01.
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also induced a new E2-dependent interaction between the enhancer and the gene terminus region. Similarly, for the KCNK5 locus, E2 treatment caused a clear increase in loops from enhancer to promoter, as well as to other regions near the terminator and promoter (Fig. 3f ).
These observations indicate that a major effect of ligand is to enhance specific promoter-enhancer interactions in parallel to induction of eRNA. We next investigated whether E2-induced enhancer-promoter interactions are affected by eRNAs. The NRIP1 locus exhibited specific enhancer-promoter and promoter-gene-terminus loops, whereas treatment with LNA against NRIP1 eRNA caused a marked inhibition of these interactions (Fig. 3h ) and E2 activation of the NRIP1 gene (Fig. 3g) . siRNA-mediated GREB1 eRNA knockdown also coordinately inhibited GREB1 gene induction and the two specific enhancer-promoter interactions induced by E2 and two additional non-enhancer loops (Fig. 3i, j) . Together these experiments indicate that oestrogen causes quantitative, as well as some qualitative, alterations in the interactions between enhancers and coding-gene promoters, and that eRNAs are of functional importance, at least under the experimental conditions here, for enhancer-promoter interactions.
To address the possibility that eRNAs might also work in trans, we first estimated the absolute expression levels of the eRNAs, finding that most of the eRNAs we investigated were present at levels of ,5-15 copies per cell, although several, including TFF1 eRNA, were present at ,70-95 molecules per cell ( Supplementary Fig. 4a, b) , suggesting that these eRNAs were likely to function primarily in cis. Furthermore, we used chromatin isolation by RNA purification (ChIRP) 25 to identify potential sites where FOXC1 eRNA localizes in the genome; despite robust detection of FOXC1 eRNA from its transcribing site-establishing the efficacy of the biotin-labelled probes used ( Supplementary  Fig. 4c )-only 15 peaks could be confidently called, and for none was the nearest gene E2 regulated (Supplementary Fig. 4c ). In addition, qPCR analysis after knockdown of FOXC1 eRNA revealed no significant effects on E2 activation of NRIP1, TFF1, PGR or KCNK5 genes (Fig. 2c) . GRO-seq after LNA transfection against FOXC1 eRNA revealed that a large majority (.95%) of the E2-upregulated coding genes continued to exhibit clear E2-dependent upregulation. Therefore, any trans effects of eRNAs are likely to be relatively infrequent or quantitatively small. Of course, there are inevitably indirect effects observed after knockdown of any eRNA that downregulates a functional coding gene. However, at least for a few gene areas, there may be effects of enhancer-based long-range interactions. We identified at least one such example, between the NRIP1 and TFF1 loci, separated by ,27 Mb on chromosome 21, exhibiting an E2-induced increase of colocalization by fluorescence in situ hybridization (FISH; Supplementary Fig. 5a-c) . Surprisingly, knockdown of NRIP1e eRNA by LNA caused a clear decrease in the interactions between these two genomic loci ( Supplementary Fig. 5b, c) , suggesting that such E2-induced colocalization was eRNA dependent.
Because several studies have implicated a role for cohesin in chromosomal interactions and enhancer-promoter looping events [26] [27] [28] , we investigated whether cohesin was involved in the observed eRNA functions. First, co-immunoprecipitation showed that ER-a can interact with cohesin subunits (Fig. 4a) . ChIP-Seq revealed that ,30-40% of RAD21 (a subunit of cohesin) binding sites overlap with putative H3K4me1/H3K27ac-marked enhancers in MCF-7 cells 28 (Supplementary Fig. 7h ). After E2 treatment, both ChIP-Seq (Fig. 4b) and ChIPqPCR data revealed a reproducible, but modest (50-200%), increased occupancy of RAD21 and SMC3 on the interrogated enhancers, as exemplified by FOXC1e, NRIP1e and TFF1e (Fig. 4e and Supplementary Fig. 6a) . By in vitro transcribed (IVT) RNA pull-down, the investigated eRNAs could pull-down SMC3 and RAD21 from MCF-7 nuclear extracts ( Fig. 4c and Supplementary Fig. 6b ). RIPqPCR confirmed the interaction between cohesin and several eRNAs, to selected regulated eRNAs but not to GAPDH or TUG1. RT, reverse transcriptase. e, ChIP-qPCR analyses represent the inhibitory effect from knockdown of NRIP1e (siRNA and LNA), FOXC1e or TFF1e on E2-induced RAD21 additional recruitment, but not on H3K4me1 binding. f, Effect of RAD21 depletion on the physical interaction between promoter-enhancer for the GREB1 and NRIP1 genes, assessed by 3C assay. E, enhancer; P, promoter. g, 1,309 E2-induced coding genes were defined by GRO-seq from the control siRNA (siCTL; 6 E2) group, and then their fold changes (log 2 FC) in siCTLversus siSMC3-transfected MCF-7 cells were plotted. Data show mean 6 s.d.; (n 5 3). *P , 0.05, **P , 0.01.
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but not with GAPDH or another nuclear RNA, TUG1 (Fig. 4d) . To test possible direct or indirect involvement of RNAs in cohesin recruitment to enhancers, we found that RNase treatment caused some decrease of the cohesin level in the chromatin-bound fraction of cells ( Supplementary  Fig. 6c ). Knockdown of specific eRNAs by LNA or siRNA resulted in a decrease of cohesin recruitment (Fig. 4e) to enhancers in response to E2, with no significant alteration of the H3K4me1 mark (Fig. 4e) , or liganddependent increase of ER-a recruitment ( Supplementary Fig. 2d, e) . Expression levels of cohesin subunits were not affected by knockdown of eRNAs (Supplementary Fig. 7a ). siRNA-mediated depletion of RAD21 caused loss of enhancer-promoter interactions, both basal and E2 induced, when assessed by chromatin conformation capture (3C) assay for the NRIP1 and GREB1 loci (Fig. 4f) . When we tested the role of cohesin in the oestrogen transcription program by GRO-seq, we noted that siSMC3 caused a broad inhibition of coding gene activation by E2 ( Fig. 4g and Supplementary Fig. 7e, f) , with only ,34% of E2-upregulated genes remaining induced ( Supplementary Fig. 7g ). Similarly, RAD21 knockdown inhibited E2 induction of genes, as revealed by the five targets evaluated (Supplementary Fig. 7d ). We excluded alterations in levels of ER-a as the cause for these marked effects of cohesin depletion (Supplementary Fig. 7b, c) . On the basis of these results, we speculate that many regulatory genomic regions, such as enhancers, harbour the cohesin complex, which 'poises' the enhancer for the stable eRNA-induced looping necessary for gene activation events. However, we cannot exclude the possibility that the role of cohesin could also reflect non-enhancerbased regulation. Despite the discovery of enhancers more than 35 years ago 1, 2 , a full understanding of the mechanisms by which they regulate gene expression has been difficult to achieve. We have provided several lines of evidence that induced eRNA transcripts are functionally important for the actions of oestrogen-regulated gene enhancers, at least in part by contributing to the dynamic generation or stabilization of enhancer-promoter looping between the regulated coding transcription units and these ER-a-bound enhancers.
METHODS SUMMARY
MCF-7 cells were initially obtained from ATCC, maintained in culture and treated as described previously 12 . They were hormone stripped for 3 days and treated or untreated with 100 nM oestradiol for 1 h to induce oestrogen target gene expression. Custom siRNAs were designed in-house and chemically synthesized by Bioneer and Sigma-Aldrich, whereas LNAs were designed and synthesized by Exiqon. Knockdown experiments with either siRNAs or LNAs were performed as transient transfections using Lipofectamine 2000, as per the manufacturer's instructions (Invitrogen). For siRNAs, hormone-stripped cells were subjected to two rounds of transfection and then treated with either vehicle or E2 for 1 h; for LNAs, cells were cultured for 24 or 48 h after transfection and exposed to the same treatment as described earlier. Real-time qPCR was carried out as previously described 9, 12 , normalized to either ACTD or GAPDH. FISH experiments were carried out as detailed previously 29 , using commercially available bacterial artificial chromosome (BAC) probes obtained from Empire Genomics (Supplementary Table 1 ). The high-throughput sequencing libraries were prepared as per Illumina's HiSeq 2000 library reagent kit. Global run-on sequencing experiments (GRO-seq) were performed as previously reported 9, 30 . 3D-DSL used a conventional 3C step for ,200 kb surrounding each interrogated E2-regulated gene TSS, and was performed as previously described 22 , with all donor and acceptor probes designed using HindIII restriction sites. ChIP-Seq for ER-a, H3K4me1, H3K27ac and RAD21 were performed as described 9 . Detailed descriptions of bioinformatic analyses are provided in Methods.
Full Methods and any associated references are available in the online version of the paper.
METHODS
Antibodies. The antibodies used in this study were: anti-ER-a (HC-20, Santa Cruz); anti-H3K4me3 (07-473, Santa Cruz); anti-H3K4me1 (ab8899, Abcam); anti-H3K27ac (ab4729, Active Motif); anti-RAD21 (ab992, Abcam); anti-SMC3 (ab9263, Abcam); anti-a-tubulin (T5168, Sigma), anti-GAL4 (DNA-binding domain (DBD)) (06-262, Millipore); and anti-IgG (I5006, Sigma). Cell culture. MCF-7 cells obtained from ATCC were cultured in DMEM media supplemented with 10% FBS in a 5% CO 2 humidified incubator. They were hormone stripped for 3 days in phenol-free media with charcoal-stripped FBS before receiving 100 nM E2 (Sigma) or ethanol treatment for 1 h for oestrogen signalling induction. MCF10A cells were a gift from B. H. Park and were essentially grown as described previously 31 . For E2 induction of MCF10A, the culture media was stripped of EGF. siRNA and LNA transfections. LNAs were obtained from Exiqon; siRNAs were from Bioneer and Sigma-Aldrich (Supplementary Tables 2 and 3 ). For transfection of both siRNA and LNAs, cells were first hormone stripped for 1 day followed by siRNA/LNA (both at 40 nM) transfection using Lipofectamine 2000. After 2 days they were then treated with ethanol or E2 for 1 h. For some experiments, transfections were performed twice to achieve higher efficiency. Similarly, LNA transfections were performed 2 days after starvation in stripped media, and thus the LNA treatment lasted 24 h in some experiments. RT-qPCR. RNA was isolated using Trizol (Invitrogen) or RNeasy column (Qiagen), and total RNA was reverse transcribed using SuperScript III Reverse Transcriptase (Invitrogen). Quantitative PCRs were performed mostly with StepOne Plus (Applied Biosystem). For normalization, DC t values were calculated relative to the levels of ACTB/GAPDH transcripts. The experiments were repeated at least three times, and one representative plot is shown in figures; most P values were obtained using a two-tailed Student's t-test. Primers are listed in Supplementary Table 4 . ChIP-Seq. ChIP was performed as previously described 9 . Briefly, approximately 10 7 cells were cross-linked with 1% formaldehyde at room temperature (,25 uC) for 10 min and neutralized with 0.125 M glycine. After sonication, ,75 mg soluble chromatin was incubated with 1-5 mg of antibody at 4 uC overnight. Immunoprecipitated complexes were collected using Dynabeads A/G (Invitrogen). Subsequently, immuno-complexes were washed, and DNA was extracted and purified by QIAquick Spin columns (Qiagen). For ChIP-Seq, the extracted DNA was ligated to specific adaptors followed by deep sequencing with the Illumina's HiSeq 2000 system according to the manufacturer's instructions. Usually, the first 48 bp for each sequence tag returned by the Illumina Pipeline was aligned to the hg18 assembly using BFAST or Bowtie2. Only uniquely mapped tags were selected for further analysis. The data was visualized by preparing custom tracks on the UCSC genome browser using HOMER 32 (http://biowhat. ucsd.edu/homer). The total number of mapable reads was normalized to 10 7 for each experiment presented in this study. Identification of ChIP-Seq peaks. The ChIP-Seq peaks were identified by HOMER. Given different binding patterns of transcription factors and histones, parameters were optimized for the narrow tag distribution characteristic of transcription factors by searching for high read-enrichment regions within a 200-bp sliding window. Regions of maximal density exceeding a given threshold were called as peaks, and adjacent peaks were set to be .500 bp away to avoid redundant detection. The common artefacts from clonal amplification were circumvented by considering only one tag from each unique genomic position. The threshold was set at a false discovery rate (FDR) of 0.001 determined by peak finding using randomized tag positions in a genome with an effective size of 2 3 10 9 bp. For ChIP-Seq of histone marks, seed regions were initially found using a peak size of 500 bp (FDR ,0.001) to identify enriched loci. Enriched regions separated by ,1 kb were merged and considered as blocks of variable lengths. All called peaks were then associated with genes by cross-referencing with the RefSeq TSS database. Peaks from individual experiments were considered overlapping if their peak centres were located within 200 bp (for some analyses the distance between them could extend to 1 kb). The peaks within 61 kb apart from the RefSeq gene TSS site were considered to be promoter bound. GRO-seq. GRO-seq experiments were performed as previously reported 9, 30, 33 . Briefly, MCF-7 cells were swelled in swelling buffer (10 mM Tris-Cl pH 7.5, 2 mM MgCl 2 , 3 mM CaCl 2 ) for 5 min on ice and then lysed in lysis buffer (swelling buffer with 0.5% IGEPAL and 10% glycerol) before being finally re-suspended in 100 ml of freezing buffer (50 mM Tris-Cl pH 8.3, 40% glycerol, 5 mM MgCl 2 , 0.1 mM EDTA). For the run-on assay, re-suspended nuclei were mixed with an equal volume of reaction buffer (10 mM Tris-Cl pH 8.0, 5 mM MgCl 2 , 1 mM dithiothreitol (DTT), 300 mM KCl, 20 units of Superase-In, 1% sarkosyl, 500 mM ATP, GTP, Br-UTP and 2 mM CTP) and incubated for 5 min at 30 uC. The nuclear-run-on RNA (NRO-RNA) was then extracted with TRIzol LS reagent (Invitogen) following the manufacturer's instructions. After base hydrolysis on ice for 40 min and followed by treatment with DNase I and antarctic phosphatase, the Br-UTP-labelled NRO-RNA was purified by anti-BrdU argarose beads (Santa Cruz Biotech) in binding buffer (0.53 SSPE, 1 mM EDTA, 0.05% Tween) for 3 h at 4 uC while rotating. Then T4 PNK (NEB) was used to repair the end of NRO-RNA. Subsequently, complementary DNA synthesis was performed as reported 9, 33 with few modifications. The RNA fragments were subjected to the poly-A-tailing reaction by poly-A polymerase (NEB) for 30 min at 37 uC. Reverse transcription was then performed using superscript III (Invitrogen) with oNTI223 primer (for sequence see Supplementary Table 5 ). The cDNA products were separated on a 10% polyacrylamide TBE-urea gel with the right product (,100-500 bp) being excised and recovered by gel extraction. After that, the first-strand cDNA was circularized by CircLigase (Epicentre) and re-linearized by Ape1 (NEB). Re-linearized single-strand cDNA was separated by TBE gel and the products of the desired size were excised (,120-320 bp) for gel extraction. Finally, the cDNA template was amplified by PCR using the Phusion High-Fidelity enzyme (NEB) with primers oNTI200 and oNTI201 for deep sequencing (primers listed in Supplementary Table 5 ). Computational analysis of GRO-seq. The sequencing reads were aligned to hg18 using Bowtie2. For analysing oestrogen effects on gene transcription, we counted the reads from the first 30 kb (assuming an RNA polymerase speed of ,0.5 kb min 21 during 1 h E2 treatment) of the entire gene body, excluding the promoterproximal region on the sense strand with respect to the gene orientation by using BED Tools or HOMER. EdgeR (http://www.bioconductor.org/) was used to compute the significance of the differential gene expression (FC $ 1.5, FDR # 0.01). Additionally, a read density threshold (that is, normalized GRO-seq read counts per kb) was used to exclude lowly expressed genes. De novo identification of GRO-seq transcripts. GRO-seq read densities were analysed in a similar manner to ChIP-Seq. Provided that GRO-seq generated strand-specific data, separate tracks were uploaded onto the UCSC genome browser; tag-enriched sites were identified using a sliding window of 250 bp. Transcript initiation sites were identified as regions where the GRO-seq read density was increased threefold relative to the preceding 1 kb region. Transcript termination sites were defined by either a reduction in reads below 10% as compared to that of the TSS or when another transcript's start was identified on the same strand. Individual high-density peaks spanning a region less than 250 bp were considered artefacts and removed from the analysis. Transcripts were defined as putative eRNAs if their de novo called start sites was located distal to the RefSeq TSS ($3 kb) and were associated with ER-a and H3K27ac co-bound regions. Bioinformatics characterization of ER-a enhancers. The ER-a-H3K27ac cobound regions are defined as those in which the distance from the centre of an ERa peak to the H3K27ac peak-occupied region is #1 kb. Overall, two methods were used to assign the ER-a-bound enhancers to E2-upregulated genes: (1) identifying the E2-upregulated coding genes from GRO-seq first and then coupling each of them to their closest ER-a-H3K27ac co-bound enhancer within a certain distance (200 kb) (a 'gene-centric' view); and (2) characterizing the ER-a-H3K27ac cobound enhancers first and then coupling each of them to their closest TSS that belongs to 1,309 E2-upregulated coding genes (an 'enhancer-centric' view). The comparison of ChIP-Seq tag intensity, GRO-seq transcription levels or distances between different categories ( Figs 1 and 4 and Supplementary Fig. 1 ) are presented as boxplots by using either log or normal scales. The P values were determined by two-tailed Student's t-test. ChIRP-Seq. The ChIRP experiment was performed essentially as per the original protocol 25 , except for a few modifications. First, we designed antisense DNA probes targeting FOXC1 eRNA ('odd' and 'even') (,40-base oligonucleotide) based on high oligonucleotide specificity (using BLAST and BLAT), moderate GC content (40-60%) and a T m around 65 uC, with probes for lacZ RNA as control (all probes listed in Supplementary Table 8 ). All DNA probes were biotinylated and purified using the Label IT Nucleic Acid Labelling Kit (Mirus Bio). The sequencing reads were aligned to hg18 by Bowtie2 and the peaks were called by HOMER if they fulfilled three criteria: (1) they were consistently called in both the 'odd' and 'even' ChIRP-Seqs; (2) they did not intersect with the peaks in the ChIRP-Seq for lacZ RNA sample; and (3) they did not intersect with the satellite repeats or retrotransposon sequences. The remaining ChIRP peaks were divided into two categories: (1) highly confident peaks (peak score .8); and (2) weak peaks (peak score # 8). The peaks were extended with 1 kb for intersection analysis by using BedTools, and the peak annotation was carried out in HOMER. RNA copy number quantification. To quantify each transcript, the PCR product using the qPCR primers for the transcript was purified and the concentration was measured. The absolute copy numbers of the PCR product were calculated as per the following. For example, for GAPDH, the number of single-stranded (ss)DNA molecules from 1 ml of the 17 ng ml 21 . Using these PCR products with known molecule copy numbers, standard curves can be generated by qPCR, which forms the basis of the quantification of the number of copies of eRNAs from cDNA samples. For cDNA samples, 3 mg of total RNA (which is, according to the QIAgen manual, ,2 3 10 5 cells) were converted into 20 ml cDNA. During multiple qPCR experiments using cells from different batches, the cycle number of target eRNA being amplified will vary within 2-3 cycles (,4-8 fold) . The copy number of GAPDH mRNA is largely consistent with previous reports 34 . Considering that the efficiency of reverse transcriptase on GAPDH mRNA is estimated to be ,50% (ref. 35) , which might be even lower for eRNAs, the real numbers of eRNA copies could be higher than the estimation. Immunoprecipitation. Cells were collected with cold PBS and lysed with RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 0.5 mM DTT, protease inhibitor). The lysate was diluted 2-4 times with dilution buffer (50 mM Tris pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.1% NP-40 and 10% glycerol, protease inhibitor). 2-5 mg of antibodies were added into the diluted cell lysate and incubated overnight at 4 uC. The next day, the protein complexes were collected by magnetic Dynabeads G for 2 h at 4 uC with rotation. The beads-antibody-protein complexes were then washed four times with wash buffer (50 mM Tris pH 7.4, 125 mM NaCl, 1 mM EDTA and 0.1% NP-40) and boiled for western blot analysis. RIP and IVT RNA pull-down. The RIP experiment was done largely as per a previous protocol 36 . Briefly, cells were cross-linked with 0.3% formaldehyde for 10 min at 37 uC. 2.5 M glycine was added (1/20 of the medium volume) to neutralize for 10 min at room temperature. The cell pellet was re-suspended in 0.6 ml of RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 0.5 mM DTT, protease inhibitor and Superase-In 40 units per ml), sonicated once and incubated on ice with frequent vortex for 25 min. Subsequently, the supernatant was diluted with RIP dilution buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM MgCl 2 , 0.05% NP40) and pre-cleared with ,25 ml protein A sepharose slurry for 30 min at 4 uC. Antibodies were added and incubated overnight at 4 uC with rotation. The next day, the RNA-protein complex was collected using pre-washed ,60 ml protein A sepharose beads for 1.5-2.5 h at 4 uC. After washing in RIPA buffer and RIPA-500 buffer (RIPA with higher salt: 500 mM NaCl), the beads were re-suspended in 150 ml of RIPA buffer with proteinase K at 45 uC for 45 min. RNA was extracted with TRIzol followed by DNaseI digestion. Reverse transcription was performed with SuperScript III RT kit (Invitrogen). For RIP-qPCRs, the amount of RNA in pull-down samples was calculated as the percentage of input GAPDH RNA of its respective group. The assay was repeated at least two times but was presented as a representative plot. P values were obtained using two-tailed Student's t-test.
For IVT RNA pull-down, first, plasmids carrying DNA sequences of the eRNA being investigated were linearized and in vitro transcribed using MEGAtranscript kit (Ambion) with 25% of UTP being replaced by biotinylated UTP (Ambion). About 10 mg of biotinylated RNA was heated to 90 uC for 3 min, put on ice for 2 min and added into RNA structure buffer (10 mM Tris pH 7.2, 0.1 M KCl, 10 mM MgCl 2 , 1 ml Superase-In) for 20 min to form a structure. The biotinylated RNA was then mixed with pre-washed Streptoavidin magnetic beads and incubated at room temperature for 30 min to conjugate the RNA with the beads, following the manufacturer's protocol. After that, ,10 mg nuclear extract in RIP buffer (20 mM Tris pH 7.4, 1 mM EDTA, 150 mM NaCl, 0.5 mM DTT, 0.1% NP-40, 5% glycerol, protease inhibitor and Superase-In 40 units per ml) was then mixed with biotinylated RNA and incubated at 4 uC for 4 h. After being washed four times in high salt buffer (20 mM Tris pH 7.4, 500 mM NaCl, 0.05% Triton X-100, 10 units per ml Superase-In), the beads were boiled for western blots. DNA enzyme digestion methylation assay. The protocol largely follows a previous paper 17 . Briefly, genomic DNA was extracted from MCF-7 cells (AccuPrep, Bioneer) 24 h after transfection with LNA/siRNA against eRNAs, and was digested with HpaII (NRIP1e) or HhaI (FOXC1e), both from NEB, before qPCR amplification using primers (Supplementary Table 4 ) that spanned the enzyme digestion sites (Supplementary Fig. 3a) . The relative resistance to restriction digestion was calculated by dividing the amount of DNA that remained after digestion by the amount before digestion. Methyl miner assay. MCF-7 cells were transfected with LNA or siRNA for 24 h, after which they were subjected to DNA isolation using a QIAgen DNA isolation column. 1 mg of each DNA was used for Biotin-tagged-MBD peptide pull-down as per the manufacturer's protocol (Invitrogen), after which unmethylated and methylated DNA fractions were collected, purified and subjected to qPCR analysis using the primers specified (Supplementary Table 4) . FISH and imaging. The cells were processed for DNA Immuno-FISH essentially as described previously 29 , with BAC probes from Empire Genomics (Supplementary Table 1 ). MCF-7 cells were treated with ethanol or E2, grown on acid-washed poly-lysine-coated coverslips, were washed with 13 PBS and immediately fixed with freshly made 4% paraformaldehyde/PBS for 10 min. Permeabilization was achieved by incubating in PBS containing 0.5% Triton X-100 for 15 min. FISH pre-hybridization treatments include incubating the coverslips in 0.1 N HCl for 5 min at room temperature, followed by digestion with 0.01 N HCl/0.002% pepsin for 5 min at 37 uC, stopped by 50 mM MgCl 2 /PBS and equilibrated in 50% formamide/23 SSC 2 h before hybridization. 5 ml of probe/hybridization buffer mix was used per coverslip, with a hybridization programme of 76 uC for 3 min followed by overnight hybridization at 37 uC in a humidified dark chamber. The coverslips were then washed with pre-warmed WS1 (0.43 SSC/0.3% NP-40), WS2 (23 SSC/0.1% NP-40) and PBS, before being finally mounted with prolong gold-DAPI anti-fade mounting reagent (Invitrogen).
For FISH Image acquisition and data analysis 37 , images were acquired using the Leica SP5 II confocal microscopy (363 objective lens) with a resonance scanner. Z-stack data acquisition was set up across 3.2 mm thickness at 0.4 mm each step (9 steps for each three-dimensional image set). The three-dimensional images were then generated in Volocity (v.6.0.1). The FISH-positive gene loci were identified using the ''Find Object Using % Intensity'' (generally .20%) function in combination with ''Exclude Objects by Size'' (generally .0.1 mm ). The cells counted (n . 100 for each group; Supplementary Fig. 5 ) were from eight images/fields; the percentage of overlapping events from each one was calculated separately, which together generates the mean and s.d. BoxB-lN tethering assay. Similar to the previous method 18 , as described in Fig. 3a and Supplementary Fig. 8 , the BoxB tethering system uses viral RNAprotein interactions, in which BoxB is a viral RNA that can be recognized and bound by viral anti-terminator protein lN. Fusion of FOXC1 eRNA with BoxB enables the fused BoxB-FOXC1e to be bound by lN. Subsequently, lN protein was fused to the DNA-binding domain (DBD) of GAL4, which then recognizes 53UAS sites on the reporter plasmid DNA. Using this technique, BoxB-eRNA can be tethered to the 53UAS sites on a reporter plasmid with the help of the lN-GAL4 fusion protein 18 . Full-length FOXC1 eRNA was cloned in pCDNA3.1 downstream to five copies of BoxB. This construct was co-transfected along with the reporter plasmids and lN-GAL4 vector ( Supplementary Fig. 8 ), which is also based on a pCDNA3.1 vector with CMV promoter.
FOXC1 promoter was cloned in KpnI and BglII sites in pGL3-basic vector, 53UAS sites were cloned at upstream SalI site in pGL3-basic vector, FOXC1 full-length enhancer (1.2 kb) was placed just upstream to 53UAS sites at the BamHI site. For deletion of the sense eRNA, the enhancer region was amplified including the full antisense transcript, the core region and 20 nucleotides from the sense eRNA of the FOXC1 enhancer (thus called FOXC1 enh-sense del enhancer, Fig. 3c ) was also cloned at BamHI site upstream to 53UAS site ( Supplementary  Fig. 8 ). Luciferase reporter assay. Tethered plasmids alone or in combination were transfected along with Renilla-TK plasmid into MCF-7 cells that had been hormone stripped for 3 days. Six hours post-transfection, they were treated with 10 nM E2 for 24 h further, and then they were subjected to the luciferase assay using the Dual-Lucifersae reporter assay kit (Promega); plates were read in Veritas Microplate Luminometer (Turner Biosystems). 3C. 3C was performed as previously described 22, 24 . Briefly 25 3 10 6 MCF-7 cells were fixed by adding 1% formaldehyde at room temperature for 10 min, and the reaction was stopped by glycine. Lysis buffer (500 ml 10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.2% Igepal CA630, protease inhibitors) was added and cells were incubated on ice. Next, cells were lysed with a Dounce homogenizer, and the suspension was spun down at 5,000 r.p.m. at 4 uC. The supernatant was discarded and the pellet was washed twice with 500 ml ice-cold 13 NEBuffer 2 (NEB). The pellet was then re-suspended in 13 NEBuffer 2 and split into five separate 50 ml aliquots. The extracted chromatin was then digested overnight with 400 units HindIII (NEB). Each digested chromatin mixture was ligated by T4 DNA Ligase (800 units) in 20 times the initial volume for 4 h at 16 uC. The ligase step was omitted in one chromatin aliquot from the five mentioned above as the unligated control. The chromatin was subsequently de-cross-linked overnight at 65 uC and purified twice with phenol and then with a mixture of phenol, chloroform and IAA (at a ratio of 25:24:1). DNA was precipitated and pellets were airdried before re-suspending in 250 ml 13 TE buffer. To degrade any carryover RNA, 1 ml RNase A (1 mg ml 21 ) was added to each tube and incubated at 37 uC for 15 min. DNA was further purified using phenol/chloroform/IAA and precipitated. The digestion and ligation efficiencies were checked and normalized before 3D-DSL. Probe design for 3C. Donor and acceptor probes were designed on HindIII sites covering the enhancers and the gene body of the following genes: GREB1, NRIP1,
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KCNK5 and P2RY2; by using custom Perl scripts (available upon request). The chosen regions for probe design covered the most prominent ER-a binding sites as well as enhancers. The uniqueness of the probe sequences was verified by Bowtie alignment to the human genome hg18 assembly. Universal adaptor sequences that are compatible with HiSeq 2000 flow cell design were added to the probe ends for bridge amplification of the ligation products and for direct sequencing. Acceptors were phosphorylated and both acceptors and donors were pooled individually in equimolar amounts for 3D-DSL (Supplementary Table 6 ). 3D-DSL. The DSL ligation products were prepared as described previously 12, 22 . 3D-DSL was performed as described previously 22 . Briefly, after 3C efficiency estimation, equal amount of 3C chromatin was biotinylated using the Photoprobe Kit (Vector Lab). Donor and acceptor probe pools (20 fmol per probe) were annealed to the biotinylated 3C samples at 45 uC for 2 h followed by 10 min at 95 uC. The biotinylated DNA was immunoprecipitated with magnetic beads conjugated to streptavidin, and during this process unbound oligonucleotides were removed by stringent washes. The 59-phosphate of acceptor probes and the 39-OH of donor probes were ligated using Taq DNA ligase at 45 uC for 1 h. These ligated products were washed and eluted from beads and then amplified by PCR using primers A and B-AD (or primer B-BC1 and B-BC2 if bar coding was used) for deep sequencing on the Illumina HiSeq 2000, using primer A as the sequencing primer. 3D-DSL data analysis. After removing the adaptor sequences, the reads are aligned to a custom library that includes all the combinations of donors and acceptors. The alignment was performed with Novoalign, and the reads were counted for every possible interaction by using custom Perl scripts (available upon request). The reads that were generated by donor-acceptor ligations on the same restriction site were removed: the remaining number of reads included both intraand inter-chromosomal interactions. We used the median value (,6 million) of all the samples from the same sequencing run for normalization; the reads accounting for ligation products in unligated controls were subtracted. In addition to standard tools, such as my5C 38 and HiTC
39
, we used an intensity-based method to characterize the set of interactions. A related method was also used in 3C-seq procedures 40 . A P value is assigned to an interaction based on the Poisson probability distribution function, p(x) 5 e 2l 3 l
x /x!, where p(x) is the probability of an interaction, x is the interaction intensity, and l is the average interaction intensity considering all the potential interactions in the library; that is, the ratio (total number of usable reads)/(total number of all possible interactions given the set of acceptors and the set of donors). The P values were corrected for multiple testing by using the Bonferroni correction method. In addition, for each interaction, we define supplementary parameters, such as (1) fold enrichment over Poisson's l, and (2) a fold enrichment over background (where the background represents the average intensity of the ligations between the probes on the neighbouring restriction sites). We consider the interactions that meet the following criteria significant for downstream analyses: (1) a (corrected) P value ,0.01; and (2) a fold enrichment over background .2 (although for display purposes in the figure plots we may also show the weak interactions).
To generate 3D-DSL plots Matlab was used; a 10-kb window was used to bundle the interactions, except for a 20-kb window for NRIP1. The interactions were plotted using a Bezier curve between the two positions with the third point in the middle of the positions with the y-axis corresponding to the log 10 intensity. For example, if the two x-axis positions are 1 and 2, and the intensity is 4, a Bezier curve is drawn between (1,0), (1.5,4) , and (2,0). The peak locations were then added on the bottom of the plot as stated in the legend. Interactions at distances generally ,10 kb were not plotted for the NRIP1 locus.
